Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

JAMA Cardiol. 2023 Dec 1;8(12):1188. doi: 10.1001/jamacardio.2023.3781.
No abstract available

Publication types

  • Comment

MeSH terms

  • Glucose
  • Heart Failure* / drug therapy
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Stroke Volume
  • Ventricular Dysfunction, Left*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose
  • Sodium